Posts by Maxx Chatsko
Video
Maxx’s Top Stock for October 2021
Oct 1, 2021
7investing Lead Advisor Maxx Chatsko's Top Stock for October 2021 is one of the most undervalued drug developers on the market.
By Maxx Chatsko
Article
Why are $100 Billion Drug Developers Such Lousy Investments?
Sep 23, 2021
While 18 companies have crossed that valuation milestone, only one has consistently outperformed the S&P 500 after.
By Maxx Chatsko
Article
Give Your Thesis Time to Breathe, But Be Objective
Sep 22, 2021
Knowing when to sell an early-stage drug developer isn't easy, but it's nearly impossible when you're a cheerleader.
By Maxx Chatsko
Article
What’s Next for mRNA?
Sep 15, 2021
The therapeutic modality is well-suited to create vaccines for infectious diseases. What about other therapeutic areas?
By Maxx Chatsko
Premium Advisor Update
Annual 2021 Review: Maxx’s 7investing Recommendations
Sep 14, 2021
By Maxx Chatsko
Podcast
Bringing Synthetic Biology to Consumers, One Material at a Time
Sep 14, 2021
Sustainable materials might be the biggest market opportunity no one is talking about. 7investing Lead Advisor Maxx Chatsko chats with Bolt Threads CEO Dan Widmaier about the opportunities and...
By Maxx Chatsko
Article
The FDA Cracks Down on Safety for Multiple Drug Classes
Sep 10, 2021
The moves send a clear signal to drug developers, even if the immediate economic consequences are mostly limited.
By Maxx Chatsko
Podcast
7investing Market Focus: Why Are Investors So Optimistic? (8/24/21)
Sep 2, 2021
News that the FDA gave Pfizer (NYSE: PFE) full approval for its COVID-19 vaccine, as well as crude prices rallying caused all the major indexes to end the day in the green. Join Maxx Chatsko and...
By Maxx Chatsko
Podcast
7investing Market Focus: Why Long-Term Investors Don’t Worry on Red…
Sep 2, 2021
If there is one thing investors can predict, it is that there will be volatility in the stock market. Stocks can plummet 20% or more in a single day on no news. While that can be frustrating, it's...
By Daniel Kline
Video
Maxx’s Top Stock for September 2021
Sep 1, 2021
7investing Lead Advisor Maxx Chatsko's top stock to buy in September 2021 is a leading provider of genetic and molecular testing services.
By Maxx Chatsko
Article
What Will the Delta Variant Mean for the Stock Market?
Aug 22, 2021
Covid cases are up and that spooked some investors, but the effect may be short-lived.
By Daniel Kline
Article
Repligen Always Seems to Make the Right Moves
Aug 21, 2021
The bioprocess leader quietly keeps delivering for shareholders.
By Maxx Chatsko
Article
I Tracked Every Car-Related Expense for 8 Years. Here’s What…
Aug 18, 2021
What's the true cost of car ownership? My nerdy habit has provided some interesting answers.
By Maxx Chatsko
Podcast
7investing Market Focus: The Red Hot Rental Market (8/11/21)
Aug 17, 2021
Low interest rates and skyrocketing housing prices have been raising the roof on the rental market. What impact will this have on the overall US economy? 7investing lead advisors Dan Kline and Maxx...
By Daniel Kline
Article
Will We Need a Covid Vaccine Booster Shot?
Aug 13, 2021
The companies that make the shot say yes, but the answer is more complicated.
By Maxx Chatsko
Podcast
7investing Market Focus: Simon’s Malls Are Returning Back to Normal…
Aug 10, 2021
Simon Property Group has disclosed its sales have now fully recovered to their 2019 levels. Post-pandemic, what items are consumers most interested in buying from malls? 7investing lead advisors Dan...
By Daniel Kline
Advisor Update
The 7investing Recommendation That Wasn’t
Aug 9, 2021
Maxx explains how red flags prevented him from recommending a seemingly promising biopharma stock to 7investing subscribers.
By Maxx Chatsko
Podcast
The 3 Frameworks for Evaluating Gene Editing Stocks
Aug 3, 2021
Most investors have heard about gene editing, but there are many differences between the major technology platforms. 7investing Lead Advisors Maxx Chatsko and Dan Kline introduce three simple...
By Daniel Kline
Podcast
7investing Market Focus: The Fed’s Big Meeting (7/28/21)
Aug 2, 2021
Markets have been propped up by low interest rates for quite some time, yet inflation looms on everyone’s mind. What could be the impact for long-term investors? 7investing lead advisors Maxx Chatsko...
By Maxx Chatsko
Podcast
7investing Market Focus: China’s Rising Regulations (7/26/21)
Aug 2, 2021
China is threatening stricter regulations on its businesses who are listed on American exchanges. What could this mean for long-term investors? 7investing lead advisors Maxx Chatsko and Simon...
By Maxx Chatsko
Video
Maxx’s Top Stock for August 2021
Aug 1, 2021
7investing Lead Advisor Maxx Chatsko's Top Stock for August 2021 is building one of the most versatile technology platforms in genetic medicines. He thinks this under-the-radar stock has the best 10X...
By Maxx Chatsko
Article
The Mother of All Binary Events Might End in an…
Jul 22, 2021
Deciphera Pharmaceuticals is nearing the most important data readout in its history.
By Maxx Chatsko
Premium Advisor Update
7investing Biotech Recs: The Next De-Risking Events
Jul 15, 2021
By Maxx Chatsko
Podcast
How Do You Value Biotech Stocks?
Jul 6, 2021
Pre-commercial drug developers don't have traditional fundamentals to analyze, but investors can estimate the likelihood of clinical development. 7investing Lead Advisors Simon Erickson checks in...
By Maxx Chatsko
Video
Maxx’s Top Stock for July 2021
Jul 1, 2021
7investing Lead Advisor Maxx Chatsko's Top Stock to buy in July 2021 is incorporating machine learning and artificial intelligence to enable true precision medicine.
By Maxx Chatsko
Article
RNAi is Setting a High Bar for Gene Editing
Jun 23, 2021
In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases.
By Maxx Chatsko
